Clinical Trial Update: Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized controlled trial evaluating azithromycin added to hydroxychloroquine in ICU patients with COVID-19 and respiratory failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Frantisek Duska, MD, PhD | Conditions: COVID-19, Respiratory Failure | Phase 3 | Status: TERMINATED